Reproductive Considerations for Transgender Patients

Intro & GAHT Impact - Fertility Foundations First

• Transgender Man (TM): Individual assigned female at birth (AFAB) who identifies as a man.
• Transgender Woman (TW): Individual assigned male at birth (AMAB) who identifies as a woman.
• Gender-Affirming Hormone Therapy (GAHT): Medical intervention using hormones to align physical characteristics with an individual’s gender identity.
• GAHT Impact on Fertility:
  • Testosterone (for TM): Can lead to anovulation, ovarian stromal thickening, and endometrial atrophy.
  • Estrogen & Anti-androgens (for TW): May cause impaired spermatogenesis, testicular atrophy, and ↓ semen volume.
• Crucial Point: Fertility preservation options must be discussed before starting GAHT. 📌 Preserve Potential Progeny Prior (PPPP).

⭐ Effects of GAHT on gametes may not be fully reversible even after cessation; counsel thoroughly about fertility implications before treatment initiation is paramount for informed consent and future family planning options for transgender individuals seeking medical transition services.

Transmasculine Options - Oocytes & Choices

Fertility preservation (FP) should be discussed before starting testosterone (T). If already on T, temporary cessation may be needed.

• Oocyte Cryopreservation (Egg Freezing):
  • Mature oocytes retrieved after ovarian stimulation (typically 10-14 days).
  • Most established method for individuals without a current partner providing sperm.
• Embryo Cryopreservation:
  • Oocytes fertilized with sperm (partner/donor) in vitro; embryos frozen.
  • Higher post-thaw survival rates than oocytes historically, but oocyte vitrification has improved.
• Ovarian Tissue Cryopreservation (OTC):
  • Experimental; involves surgical removal of ovarian tissue.
  • Option for prepubertal individuals or when stimulation is contraindicated.

Considerations with Testosterone:

• Testosterone can suppress ovarian function; duration of T use may impact oocyte yield/quality.
• Resumption of menses after T cessation varies (avg. 3-6 months).

⭐ Ovarian stimulation for oocyte retrieval can often be completed within 2-3 weeks after temporarily stopping testosterone, allowing for timely gender-affirming medical treatment.

Transfeminine Options - Sperm Savvy Strategies

• 📌 Key Fertility Strategies (Remember "Four S"):
  • Sperm Banking (Cryopreservation):
    • Optimal: Pre-GAHT initiation. Best quality/quantity.
    • Method: Semen sample collection.
  • Stop GAHT (Attempt Recovery if on hormones):
    • GAHT (Estrogen ± Anti-androgens) suppresses spermatogenesis.
    • Temporary cessation for 3-6+ months (up to 12-24 months).
    • Recovery variable; success ↓ with prolonged GAHT.
  • Surgical Sperm Retrieval (if azoospermic post-cessation):
    • Options: Testicular Sperm Extraction (TESE), Micro-TESE (for non-obstructive azoospermia).
  • Stem Cell Research (Experimental):
    • Testicular tissue cryopreservation for future use.

⭐ Sperm cryopreservation before initiating GAHT offers the best fertility preservation outcomes for transfeminine individuals.

Parenthood & Prevention - Babies & Barriers

• Pregnancy in Transgender Men (TM)
  • Conception: Intercourse, Assisted Reproductive Technology (ART). Testosterone (T) cessation vital; menses typically resume in 2-6 months.
  • Antenatal Care: Standard, with attention to chest binding comfort, hormone monitoring (estradiol, T).
  • Delivery: Individualised (vaginal/cesarean).
  • Chestfeeding: Possible if breast tissue present; T cessation required. Induced lactation an option.
• Parenthood for Transgender Women (TW)
  • Methods: Using cryopreserved sperm (IVF, IUI with partner/surrogate), adoption, co-parenting.
• Contraception
  • Essential for all sexually active individuals with reproductive capacity if pregnancy not desired, regardless of Gender-Affirming Hormone Therapy (GAHT).
  • Options: Barrier methods, hormonal contraception (consider interactions), IUDs.

  ⭐ Testosterone therapy in TM does NOT reliably prevent ovulation or pregnancy.

High‑Yield Points - ⚡ Biggest Takeaways

• Fertility preservation counseling is crucial prior to gender-affirming hormone therapy (GAHT) or surgical interventions.
• GAHT has potential gonadotoxic effects, which may be irreversible, impacting future fertility.
• Transmen (AFAB) options include oocyte or embryo cryopreservation before hysterectomy/oophorectomy.
• Transwomen (AMAB) should consider sperm cryopreservation before GAHT or orchiectomy.
• Pregnancy is achievable for transmen with a uterus after discontinuing testosterone.
• Testosterone in transmen suppresses ovulation but is not a reliable contraceptive; discuss contraception.